HomeQuestion

How do you choose between GAP or GP for patients with borderline resectable cholangiocarcinoma?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What is your institutional practice for neoadjuvant therapy prior to transplanting cholangiocarcinoma?

Would you consider using enasidenib off-label for a cholangiocarcinoma with IDH2 mutation that has progressed on numerous lines of standard of therapy?

Under what circumstances do you give chemotherapy for a nondiagnostic pancreas biopsy that is suspicious for adenocarcinoma?

Will you offer durva-FLOT perioperatively for adenocarcinoma of the esophagus?

Given that ESOPEC did not mandate PET staging, are the conclusions of the study still applicable for patients who are staged with PET?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.